跳至主要内容
临床试验/NCT03181256
NCT03181256进行中(未招募)不适用

Early Detection of Lung Cancer in the Medically Underserved Population

Vanderbilt-Ingram Cancer Center2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2017年12月14日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
45
试验地点
2
主要终点
Candidate biomarkers of risk or of early diagnosis

研究概览

简要总结

This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors detect lung cancer at an earlier stage.

详细描述

PRIMARY OBJECTIVES:

I. To provide screening for lung cancer in an underserved and high risk population for lung cancer.

II. To collect clinical and demographic information and research bio specimens prospectively on high risk individuals.

III. To analyze the association between suspected lung cancer risk factors and outcomes such as pre-malignant lesions and diagnosis of lung cancer.

IV. To identify and validate biomarkers that are associated with lung cancer risk factors and premalignant lesions.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
55 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Current smoker or former smoker, if former smoker participants must have quit smoking within the past 15 years
  • >= 30 pack year of smoking history
  • Participant is uninsured

排除标准

  • History of diagnosis/treatment of lung cancer in the past 2 years
  • History of head/neck or esophageal cancer in the last 1 year
  • Inability to provide informed consent

结局指标

主要结局

Candidate biomarkers of risk or of early diagnosis

时间窗: Up to 5 years.

Will validate the performance of the candidate biomarkers of risk or of early diagnosis.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Grogan

Associate Professor of Thoracic Surgery

Vanderbilt-Ingram Cancer Center

研究点 (2)

Loading locations...

相似试验